Neos Therapeutics Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St hits two-week lows as rising bond yields, Walmart results drag
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Neos Therapeutics (NEOS) PT Lowered to $10 at JMP Securities
November 12, 2018 7:40 AM ESTJMP Securities analyst Jason Butler lowered the price target on Neos Therapeutics (NASDAQ: NEOS) to $10.00 (from $22.00) while maintaining a Market Outperform rating. Neos reported 3Q18 earnings slightly below consensus estimates. Product sales were consistent with the preannouncement earlier this week and ~$2MM (15%) below consensus... More
